H.C. Wainwright downgraded Timber Pharmaceuticals to Neutral from Buy without a price target after the company entered into a definitive agreement to merge with LEO Pharma for a total transaction value of $36M. The firm says it can’t be certain of the outcome with respect to the contingent value rights. It does not anticipate any rival bids.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMBR: